Related Experiment Video
Updated: Jan 27, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
Identification of fibrinogen as a natural inhibitor of MMP-2
Hassan Sarker1, Eugenio Hardy1,2, Ayman Haimour1
1Department of Biochemistry, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, T6G 2H7, Canada.
Abstract:
Non-genetic MMP-2 insufficiency is a relatively unexplored condition which could be induced by pathological overexpression of endogenous MMP-2 inhibitors such as TIMPs and/or the acute phase reactant alpha-2-macroglobulin. Here, we investigate the hypothesis that human fibrinogen (FBG) - an acute phase reactant - inhibits human MMP-2. Following an unexpected observation where sera from human donors including arthritis patients with increased levels of serum FBG exhibited reduced binding of serum proMMP-2 to gelatin, we found that human FBG (0 to 3.6 mg/mL i.e., 0 to 10.6 μM) concentration-dependently inhibited human proMMP-2 and MMP2 from binding to gelatin. Moreover, at normal physiological concentrations, FBG (5.29-11.8 μM) concentration-dependently inhibited (40-70% inhibition) the cleavage of fluorescein-conjugated gelatin by MMP-2, but not MMP-9. Indicative of a mixed-type (combination of competitive and non-competitive) inhibition mechanism, FBG reduced the Vmax (24.9 ± 0.7 min-1 to 17.7 ± 0.9 min-1, P < 0.05) and increased the Michaelis-Menten constant KM (204 ± 6 nM to 478 ± 50 nM, P < 0.05) for the reaction of MMP-2 cleavage of fluorescein-conjugated gelatin. In silico analyses and studies of FBG neutralization with anti-FBG antibodies implicated the domains D and E of FBG in the inhibition of MMP-2. In conclusion, FBG is a natural selective MMP-2 inhibitor, whose pathological elevation could lead to MMP-2 insufficiency in humans.
Insights
Human fibrinogen (FBG) acts as a selective inhibitor of matrix metalloproteinase-2 (MMP-2). Elevated FBG levels may cause MMP-2 insufficiency, a condition linked to various pathologies.
Area of Science:
- Biochemistry
- Enzymology
Background:
- Non-genetic MMP-2 insufficiency is poorly understood.
- Potential causes include overexpression of MMP-2 inhibitors like TIMPs and alpha-2-macroglobulin.
- Human fibrinogen (FBG) is an acute phase reactant with potential inhibitory roles.
Purpose of the Study:
- To investigate the hypothesis that human fibrinogen (FBG) inhibits human MMP-2.
- To explore the mechanism and domains of FBG involved in MMP-2 inhibition.
Main Methods:
- Enzyme kinetics assays measuring MMP-2 activity with varying FBG concentrations.
- Gelatin zymography to assess MMP-2 and MMP-9 binding to gelatin.
- In silico analyses and antibody neutralization studies to identify inhibitory domains of FBG.
Main Results:
- Human FBG concentration-dependently inhibited proMMP-2 and MMP-2 binding to gelatin.
- FBG selectively inhibited MMP-2 (not MMP-9) cleavage of gelatin in a mixed-type inhibition pattern.
- Domains D and E of FBG were implicated in MMP-2 inhibition.
Conclusions:
- Human fibrinogen is a natural, selective inhibitor of MMP-2.
- Pathological elevation of FBG may lead to MMP-2 insufficiency in humans.
Related Concept Videos
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
What is Natural Selection?
Nature and Nurture
Chirality in Nature
The Wave Nature of Light
Limits to Natural Selection

